Suman Golla, MD
Otolaryngology · Pittsburgh, PANPI 1245203876
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,109 of the $13,435 with a category attached, or 67.8%. AstraZeneca accounts for 93.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $8,223 and has fallen 75.9% since, to $1,980 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $344.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$13K
- Optinose US, Inc.$275
- Regeneron Healthcare Solutions, Inc.$149
- Next Science LLC$124
- Urgo Medical North America, LLC$82
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$62
- plus $190 from 5 others
What the payments were for
- Consulting fees$9,10968%
- Speaking & faculty fees$1,95015%
- Travel & lodging$1,2149%
- Food & beverage$1,1619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $12,554 |
| Optinose US, Inc. | 7 | $275 |
| Regeneron Healthcare Solutions, Inc. | 2 | $149 |
| Next Science LLC | 1 | $124 |
| Urgo Medical North America, LLC | 1 | $82 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $62 |
| Phadia US Inc. | 3 | $54 |
| Convatec Inc. | 1 | $52 |
| Mimedx Group, Inc. | 1 | $50 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Alk-abello, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,435 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 281 | $5,271 |
| Fluticasone Propionate | 332 | $2,958 |
| Famotidine | 316 | $2,330 |
| Ipratropium Bromide | 49 | $1,742 |
| Betamethasone Valerate | 36 | $900 |
| Omeprazole | 47 | $306 |
| Prednisone | 30 | $68 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Pittsburgh
- Stella LeePittsburgh$438K
- Matthew SpectorPittsburgh$56K
- Umamaheswar DuvvuriPittsburgh$48K
- Jose ZevallosPittsburgh$40K
- Thomas KaffenbergerPittsburgh$33K
- Priya KrishnaPittsburgh$20K
- Eric WangPittsburgh$15K
- Giuseppe StaltariPittsburgh$8K
- Warren SwegalPittsburgh$7K
- Carl SnydermanPittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.